Intuitive Surgical Inc (ISRG)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA and an Investment Account
Sell

$466.89

Buy

$467.50

arrow-up$6.22 (+1.35%)

Prices updated at 01 Apr 2026, 18:38 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Intuitive Surgical Inc designs, manufactures, markets da Vinci Surgical Systems, and related instruments. The da Vinci surgery, combines the benefits of minimally invasive surgery for patients with the ease of use, precision and dexterity of open surgery.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
Dr. Gary S. Guthart,PhD
CEO
Mr. David J. Rosa
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
17,021
Head office
1020 Kifer Road
Sunnyvale
United States
94086
mobile
+1 408 523-2100
letter
investor.relations@intusurg.com

Key personnel

Salary
Ms. Amal M. Johnson
Independent Director
0.09m
Dr. Craig H. Barratt,PhD
Lead Independent Director
0.08m
Dr. Gary S. Guthart,PhD
Executive Chairman of the Board
0.87m
Mr. Jamie E. Samath
Executive Vice President, Chief Financial Officer and Head of Business Technology
0.68m
Ms. Jami Dover Nachtsheim
Independent Director
0.09m
Ms. Patricia L. Wadors
Senior Vice President and Chief Human Resources Officer
-
Mr. Lewis Chew
Independent Director
0.10m
Mr. Keith R. Leonard, Jr
Independent Director
0.08m
Mr. Joseph C. Beery
Independent Director
0.08m
Mr. David J. Rosa
Chief Executive Officer, President and Director
0.86m
Mr. Gary H. Loeb
Executive Vice President, Chief Legal Officer and Chief Compliance Officer
0.62m
Ms. Sreelakshmi Kolli
Independent Director
0.08m
Dr. Amy L. Ladd, M.D.
Independent Director
0.08m
Dr. Monica P. Reed, M.D.
Independent Director
0.09m
Mr. Fredrik C. Widman
Principal Accounting Officer, Vice President and Corporate Controller
-
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
0.67m
Mr. Mark P. Brosius
Senior Vice President and Chief Manufacturing and Supply Chain Officer
0.53m
Mr. Iman Jeddi, PhD
Senior Vice President; General Manager, da Vinci Platforms and Product Operations
-

Top 5 shareholders

No. of shares
Vanguard Group Inc33,613,298
BlackRock Inc31,543,936
State Street Corp15,539,327
T. Rowe Price Associates, Inc.12,818,790
Vanguard Investments Australia Ltd11,462,070

Director dealings

Action
15 Dec 2025-
12 Dec 2025-
10 Dec 2025-
10 Dec 2025-
10 Dec 2025-
01 Dec 2025-
01 Dec 2025-
01 Dec 2025-
01 Dec 2025-
01 Dec 2025-
01 Dec 2025-
12 Nov 2025-
12 Nov 2025-
12 Nov 2025-
12 Nov 2025-
12 Nov 2025-
12 Nov 2025-
12 Nov 2025-
12 Nov 2025-
12 Nov 2025-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.